185 related articles for article (PubMed ID: 1382234)
21. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
[TBL] [Abstract][Full Text] [Related]
22. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma.
Dumont J; Charpy-Validire P; Mosseri V; Gabarre J; Belanger C; Turpin F; Binet JL; Dreyfus F; Fourquet A; Janvier M
Hematol Oncol; 1991; 9(4-5):197-207. PubMed ID: 1720759
[TBL] [Abstract][Full Text] [Related]
23. Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
Schneider AM; Straus DJ; Schluger AE; Lowenthal DA; Koziner B; Lee BJ; Wong G; Clarkson BD
J Clin Oncol; 1990 Jan; 8(1):94-102. PubMed ID: 1688617
[TBL] [Abstract][Full Text] [Related]
24. Minimizing toxicity of MACOP-B.
Connors JM; Klimo P
J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
[No Abstract] [Full Text] [Related]
25. m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.
Dana BW; Dahlberg S; Miller TP; Hartsock RJ; Balcerzak S; Coltman CA; Carden JO; Hartley K; Fisher RI
J Clin Oncol; 1990 Jul; 8(7):1155-62. PubMed ID: 1694233
[TBL] [Abstract][Full Text] [Related]
26. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D
J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207
[TBL] [Abstract][Full Text] [Related]
27. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
28. [Acute pneumocystosis during polychemotherapy following the MACOP-B protocol].
Wassermann K; Pothoff G; Heitz W; Kirn E; Krueger GR; Diehl V; Eckert G; Hilger HH
Dtsch Med Wochenschr; 1990 Nov; 115(45):1705-11. PubMed ID: 1699717
[TBL] [Abstract][Full Text] [Related]
29. MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.
Marosi C; Heinz R; Steger G; Fortelny A; Chott A; Hanak H; Radaszkiewicz T; Baur M; Kreiner G; Schwarzinger I
J Cancer Res Clin Oncol; 1992; 118(4):314-7. PubMed ID: 1374411
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
Olopade OI; Larson RA; Mick R; Watson SM; Hoffman PC; Ultmann JE; Golomb HM
Leukemia; 1990 Feb; 4(2):127-31. PubMed ID: 1689439
[TBL] [Abstract][Full Text] [Related]
31. MACOP-B treatment in children and adolescents with advanced diffuse large-cell non-Hodgkin's lymphoma.
Santana VM; Abromowitch M; Sandlund JT; Behm FG; Ayers GD; Roberson PK; Pui CH
Leukemia; 1993 Feb; 7(2):187-91. PubMed ID: 7678878
[TBL] [Abstract][Full Text] [Related]
32. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
[TBL] [Abstract][Full Text] [Related]
33. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Shipp MA; Yeap BY; Harrington DP; Klatt MM; Pinkus GS; Jochelson MS; Rosenthal DS; Skarin AT; Canellos GP
J Clin Oncol; 1990 Jan; 8(1):84-93. PubMed ID: 1688615
[TBL] [Abstract][Full Text] [Related]
34. MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study.
Vitolo U; Bertini M; Brusamolino E; Cavallero GB; Comotti B; Gallo E; Ghio R; Levis A; Luxi G; Meneghini V
J Clin Oncol; 1992 Feb; 10(2):219-27. PubMed ID: 1370690
[TBL] [Abstract][Full Text] [Related]
35. [Long-term results with MACOP-B and radiation therapy for aggressive lymphomas].
Krieger G; Kreysing E; Kneba M
Onkologie; 2001 Feb; 24 Suppl 1():49-58. PubMed ID: 11441311
[TBL] [Abstract][Full Text] [Related]
36. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection.
Taillan B; Garnier G; Ferrari E; Pesce A; Vinti H; Fuzibet JG; Dujardin P
Acta Haematol; 1993; 89(1):10-2. PubMed ID: 7683165
[TBL] [Abstract][Full Text] [Related]
37. Intensive chemotherapy for adult lymphoblastic lymphomas.
Liang R; Todd D; Chan TK; Chiu E; Lie A; Ho FC; Loke SL
Cancer Chemother Pharmacol; 1991; 29(1):80-2. PubMed ID: 1720710
[TBL] [Abstract][Full Text] [Related]
38. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
Gottlieb AJ; Anderson JR; Ginsberg SJ; Bloomfield CD; Norton L; Barcos M; Peterson BA; Nissen N; Henderson ES; Holland JF
Cancer; 1990 Nov; 66(9):1888-96. PubMed ID: 1699653
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.
Gemmati D; Ongaro A; Tognazzo S; Catozzi L; Federici F; Mauro E; Della Porta M; Campioni D; Bardi A; Gilli G; Pellati A; Caruso A; Scapoli GL; De Mattei M
Haematologica; 2007 Apr; 92(4):478-85. PubMed ID: 17488658
[TBL] [Abstract][Full Text] [Related]
40. Updated clinical experience with MACOP-B.
Klimo P; Connors JM
Semin Hematol; 1987 Apr; 24(2 Suppl 1):26-34. PubMed ID: 2438779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
